Clinician barriers, perceptions, and practices in treating patients with hepatitis C virus and substance use disorder in the United States

Clinician barriers, perceptions, and practices in treating patients with hepatitis C virus and substance use disorder in the United States

The likelihood of clinicians prescribing direct-acting antiviral (DAA) therapy for patients with chronic hepatitis C virus (HCV) and substance use disorder (SUD) was assessed via a survey emailed throughout the United States to clinicians (physicians and advanced practice providers) in gastroenterol...

Full description

Bibliographic Details
Main Authors: Haesuk Park, Carolyn Brown, Debbie L. Wilson, Pei-Lin Huang, Pilar Hernández-Con, Patrick Horne, Amie Goodin, Amanda Joseph, Rich Segal, Roniel Cabrera, Robert L. Cook
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:Preventive Medicine Reports
Subjects:
HCV
Direct-acting antivirals
Survey
SUD
Medicaid
Online Access:http://www.sciencedirect.com/science/article/pii/S2211335523000293

Internet

http://www.sciencedirect.com/science/article/pii/S2211335523000293

Similar Items